Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

The HeartBeam AIMIGo device is approximately the size of a credit card and uses the company’s patented 3D vectorelectrocardiography (3D VECG) technology to capture signals from three different projections and deliver a synthesized 12-lead ECG.

New research underway on credit card-sized heart monitor that synthesizes 12-lead ECGs

The portable device uses HeartBeam's patented 3D vectorelectrocardiography (3D VECG) technology to capture signals from three different projections and deliver a synthetic 12-lead ECG.

March 14, 2024
Dexcom, a global healthcare technology company based out of San Diego, has received the first over-the-counter U.S. Food and Drug Administration (FDA) clearance for a wearable glucose biosensor that can be obtained without a prescription, the Stelo..

FDA clears first over-the-counter wearable device for continuous glucose monitoring

The newly cleared device is worn on the back of the arm and sends data directly to the user's smartphone. 

March 6, 2024
Left, the FIRE1 heart failure remote monitoring device that gets implanted into the IVC to measure fluid volume status. Right, the external belt monitoring device worn by the patient that can alert clinicians about status changes so interventions can be done before a patient requires a hospital admission. 

Early feasibility study for implantable heart failure monitor moves forward 

Startup vendor FIRE1 completed patient enrollment in its U.S. early feasibility study for a heart failure remote monitoring device that directly measures fluid volume inside the IVC.

February 28, 2024
The U.S. Food and Drug Administration (FDA) has issued a new warning against the use of watches, rings and other devices that claim to measure blood glucose levels without piercing the skin. These unapproved devices come from “dozens of companies” and are sold “under multiple brand names.”

FDA warns against use of unauthorized smartwatch, smart ring devices to measure blood glucose levels

Any devices that claim to make blood glucose measurements without piercing the user's skin are associated with a heightened risk of error, the agency said. 

February 22, 2024
Multiple factors can interfere with pulse oximetry accuracy including skin pigmentation. Multiple studies have shown the inaccuracy of current pulse oximeters in patients with darker skin tones than whites, often over estimating their oxygenation when in fact they are hypoxic. Images courtesy of Masimo.

Inaccurate pulse oximeter readings impact Black heart failure patients and FDA plans to address this

Black patients are already less likely to receive LVADs or transplants compared to whites, and these inaccurate readings can further widen the disparities.

February 21, 2024
money business cash flow dollar. Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was funded with $5.4 million in cash and $5.6 million in debt financing.

Medical device company raises $136M to continue work on new 2-in-1 heart failure technology

New Jersey-based Impulse Dynamics says it will use the new financing to fund clinical research and continue developing advanced heart failure devices. 

February 14, 2024
Medtronic shared new STROKE AF data on the Reveal Linq ICM

Medtronic ICM a cost-effective approach for reducing the risk of ischemic stroke

Remote monitoring with the Reveal Linq insertable cardiac monitor can improve outcomes without breaking the bank, according to new data being presented at the International Stroke Conference in Phoenix.

February 7, 2024
Element Science Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)

New patch-based wearable defibrillator receives CE mark approval

The device, which also received Great Britain’s UKCA marking, was specifically designed to be less bulky and easier to wear than other wearable cardioverter-defibrillators.

January 26, 2024